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Abstract 38 
The use of animal products in the derivation and maintenance of human pluripotent stem cells 39 
(hPSCs) limits their possible applications in research and in clinics. Thus, one of the major goals 40 
in regenerative medicine is the establishment of animal-free conditions to support the culture and 41 
differentiation of human stem cells. Human fibroblasts produce an extracellular matrix (ECM) 42 
which can be extracted without the use of detergents, sterilized, and then used to coat tissue 43 
culture plates. 44 
We have shown that human embryonic stem cells (hESCs) grown on this matrix maintain their 45 
pluripotency in the presence of medium conditioned by fibroblast cells, and that these cells 46 
maintain expression of surface proteins (SSEA4, Tra1-60, Tra1-81), alkaline phosphatase activity 47 
and specific intracellular markers (Nanog, Oct-4, Tert, FoxD3) in hESCs. This growth system 48 
reduces exposure of hPSCs to feeder layers and animal ingredients, thereby limiting the risk of 49 
pathogenic contamination and additionally, facilitating their manipulation. Herein we present an 50 
improved version of our previous protocol for extracting ECM from human foreskin fibroblast 51 
using a different buffer. Our new hypotonic shock method is detergent-free, reduces costs, and 52 
preserves the integrity of the extracted ECM. This improved protocol has been validated for 53 
undifferentiated-state hPSC maintenance (more than 40 passages), stem cell differentiation and 54 
for cell migration assays. 55 
 56 
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1. Introduction 61 
The stem cell biology field is continually transforming, especially in recent years with the 62 
introduction of several validated protocols for obtaining human-induced pluripotent stem cells 63 
(hiPSCs) (1,2), which have created new avenues for studying different diseases and regenerative 64 
medicine applications. Several human embryonic stem cell (hESC) and hIPSC lines have been 65 
derived and grown using mouse feeder layers, Matrigel®, or other animal reagents (3,4). 66 
However, recent successes using pluripotent stem cell (PSC) derivatives in clinical trials (5,6) 67 
have emphasized the need for improved quality standards before these derivatives are applied in 68 
cell therapies. In particular, new culture methods must be developed that circumvent the need for 69 
animal products because these might provoke infections or immune rejection following 70 
transplantation into patients (7). Thus, chemically defined culture systems that are devoid of 71 
nonhuman substances will greatly facilitate the use of human stem cells (hSCs) in therapies. 72 
Extracellular matrix (ECM) modulates cellular adhesion processes and signaling inside stem cell 73 
niches and is essential for maintaining their structure and supportive qualities (8,9). An attractive 74 
alternative to the use of feeder cells, and the complications associated with them, is the 75 
development of an animal-free ECM, and there would be many advantages to maintaining PSCs 76 
on such supports. Indeed, undefined mixtures of natural and synthetic matrix proteins are already 77 
used as a coating for in vitro human stem cell culture (10), but unfortunately, most of these 78 
reagents are cost-prohibitive for many laboratories. Decellularization procedures are traditionally 79 
used to isolate ECM from cells and organs (11), facilitating remodeling in animal models and 80 
humans. However, the procedures used to remove the cells, especially detergent-based methods, 81 
can alter the native structure of the ECM (12,13). 82 
We previously published a protocol which allows long-term growth of undifferentiated hESCs on 83 
human functional foreskin ECM (hffECM), extracted by using RIPA buffer and cultured using 84 
human foreskin conditioned medium, in the Methods in Molecular Biology series (14). Here we 85 
present a modification of our previous protocol which replaces RIPA with a simple, low-cost 86 
hypotonic buffer without detergents. The hffECM obtained is capable of maintaining the 87 
pluripotency of hESCs for more than 40 passages (12). Additionally, our hffECM has also been 88 
validated as a coating for directed-differentiation experiments by using both hESCs and 89 
mesenchymal stem cells (MSCs) and as a basis for cell migration studies (12,15,16). 90 
 91 
2. Materials 92 
Growth of hPSCs using functional hECM 
DOI 10.1007/7651_2014_154 Springer Science & Business Media New York 
4 
2.1. Culture of Human Foreskin Fibroblast for Derivation of Conditioned Media and Human 93 
Functional Foreskin-derived Extracellular Matrix (hffECM) 94 
1. Human foreskin fibroblasts (ATCC, Catalogue No. CRL-2429, Passages 11--18; see Note 1). 95 
2. Iscove’s medium (Sigma, St. Louis, MO), supplemented with 10% human serum (HS), 1% 96 
Glutamax (GIBCO, Invitrogen, Carlsbad, CA). 97 
3. Gelatin (1.5%; Sigma). In a sterile bottle, add embryo-tested water (Sigma) to gelatin. Warm 98 
the mixture to 37º C in a water bath using a shaker. Store at 4º C or make aliquots and keep them 99 
frozen at -20º C. These aliquots can be stored for up to 6 months. Before proceeding with tissue 100 
culture, thaw the aliquots and dilute them to 0.01% with sterile Dulbecco’s PBS (DPBS) 101 
(Invitrogen). Pass the solution through a 0.22 µm filter (Nalgene, Hereford, UK). Coat the culture 102 
surfaces by pipetting 1 mL/well into 6-well plates (BD, San Jose, CA) or 12 mL into a 75 cm2 103 
flask (Iwaki, Ibaraki, Japan). Allow the gelatin to settle at 37º C for 30 min. Plates may be used 104 
immediately or stored at 4º C to prevent evaporation. 105 
4. Mitomycin C (Fluka, Buchs, Switzerland) is dissolved in Iscove’s medium (Sigma) at 1 106 
mg/mL, stored at 4º C and then added to the cultures as required. 107 
5. Triple Select (GIBCO, Invitrogen) is used instead of trypsin to detach cells from the tissue 108 
culture plates. 109 
6. DPBS without Ca2+ or Mg2+, pH 7.4 (GIBCO, Invitrogen). 110 
7. Trypan Blue (Sigma) to count and evaluate cell viability (see Note 2). 111 
8. Neubauer haemocytometer (Brand, Wertheim, Germany). 112 
2.2. Derivation of Conditioned Media 113 
As previously described (17), TESR1 medium is usually used as the base media for human 114 
foreskin fibroblast conditioning, using passage 11 to 18 cells. 115 
1. TERS1 conditioned media: after collection media can be frozen at -80º C for up to 6 months 116 
(see Notes 3 and 4). 117 
2.3. Preparation of Human Functional Foreskin-derived Extracellular Matrix (hffECM) 118 
1. Osmotic lysis buffer Tris-EDTA (TE) pH 7.4: 10mM TrisHCl pH 7.4, 1mM EDTA pH 8 (all 119 
from Sigma). For preparation details see Note 5. 120 
2. Cell scrapers (Falcon, BD Biosciences, Madrid). 121 
3. DPBS (GIBCO, Invitrogen). 122 
2.4. Preparation of Samples for Transmission Electron Microscopy (TEM) 123 
1. PB (EMS). 124 
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2. Glutaraldehyde (3%): dilute glutaraldehyde (Electron Microscopy Science [EMS], Hattfield, 125 
PA) from a 25% (v/v) stock in PB. 126 
3. Petri dish (Falcon, BD). 127 
4. Disposable Pasteur pipettes (Falcon). 128 
5. Osmium 1% (Sigma): prepared by diluting osmium in PB. 129 
6. Uranyl acetate (2%) diluted in 70% ethanol. 130 
7. Preparation of alcohol gradient: use the appropriate volume of absolute ethanol (Merck), mixed 131 
with distilled water to prepare 30%, 50%, 70%, and 90% ethanol solutions. 132 
8. Resin LR-White (EMS). 133 
See Note 6 for safety measures that must be adopted to perform this technique. 134 
2.5. Preparation of Samples for Atomic Force Microscopy (AFM) 135 
1. 0.1 M PBS (Gibco) 136 
2. 2% paraformaldehyde/2.5% glutaraldehyde/PB (all from EMS). 137 
3. Series of ethanol/water solutions (30%, 50%, 70%, 90%, 96%). All from Sigma. 138 
4. Absolute ethanol (Sigma). 139 
2.6. Culture and Maintenance of Undifferentiated hESC lines 140 
1. H9 and H1 hESC lines (WiCell, Madison, WI). 141 
2. TERS1 conditioned media. 142 
3. TGF-β1 (Invitrogen): reconstituted with sterile 4 mM HCl (Sigma) containing 1 mg/mL of 143 
human serum albumin (Sigma) to a final stock solution concentration of 40 ng/mL. Store in 50 144 
µL aliquots at -20º C. 145 
4. Human recombinant basic fibroblast growth factor (bFGF; Invitrogen) is dissolved in 1 mL 146 
DMEM Knockout Medium (Invitrogen) and stored in 100 µL aliquots at -20º C. 147 
2.7. Analysis of Undifferentiated hESC Markers 148 
2.7.1. Staining of Pluripotency Cell Surface Markers by Immunocytochemistry 149 
Antibodies that detect specific cell-surface hESC markers are commercially available from 150 
Chemicon and antibodies for detection of the ECM component fibronectin are available from 151 
Sigma. Secondary antibodies are all commercially available from Invitrogen. See Tables 1 and 2 152 
for recommended dilutions and providers. 153 
1. DPBS without Ca2+, Mg2+ (GIBCO, Invitrogen).  154 
2. 4% paraformaldehyde (see recipe at 2.7.2.2). 155 
3. 0.05% sodium azide (Sigma) in DPBS. 156 
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4. Triton-X-100 (Sigma): prepare a dilution of 1% Triton-X-100 in DPBS to permeabilize the 157 
hESCs. 158 
5. Blocking solution: 4% serum in DPBS. Serum for the blocking solution should be of the same 159 
origin/animal as the secondary antibody. 160 
6. Prolong gold anti-fade reagent with DAPI (Invitrogen). See Note 7. 161 
2.7.2. Alkaline phosphatase (AP) detection kit (Chemicon Millipore, Billerica, MA) 162 
1. This kit provides two components for AP detection: Fast Red Violet solution (0.8 g/L stock) 163 
and naphthol AS-BI phosphate solution (4 mg/mL) in AMPD buffer (2 mol/L), pH 9.5. 164 
2. Paraformaldehyde 4% in PBS: Prepared fresh with distilled water. To prepare 100 mL, heat 50 165 
mL distilled water to 60º C on a hot plate in a fume hood (do not exceed 65º C) and add 4 g of 166 
paraformaldehyde powder. Stir the solution until it becomes clear (a few drops of NaOH can be 167 
added). After that, filter the solution through a 0.22 µm filter and add 50 mL of sterile PBS at pH 168 
7.4 (see Note 8). 169 
3. TBST 1✕ Rinse Buffer: prepared fresh with 20 mM Tris-HCl, pH 7.4, 0.15M NaCl, 0.05% 170 
Tween-20 (all from Sigma). 171 
2.7.3. Intracellular Markers by RT-PCR and QPCR Analysis 172 
See Table 3 for the complete list of primers and reaction conditions.  173 
1. RNeasy mini kit (74104, Qiagen). 174 
2. Deoxyribonuclease (DNase) I (RNasa-free DNase SET; 79254; Qiagen). 175 
3. High Capacity cDNA RT kit (PN 4368814; Applied Biosystems). 176 
4. FastStart PCR Master (04710436001; Roche). 177 
5. Power SYBR® Green PCR master mix (4367659; Applied Biosystems). 178 
6. PCR microplates. 179 
7. 1.5 mL sterile microcentrifuge tubes (Eppendorf, Hamburg, Germany). 180 
8. Absolute ethanol (Merck, Darmstadt, Germany). 181 
9. Standard table-top microcentrifuge capable of 13,000 × g centrifugal force. 182 
10. Standard thermal cycler. 183 
11. NanoDrop spectrophotometer or similar to evaluate the synthetized cDNA quality. 184 
2.7.4. Telomerase Activity 185 
1. TRAPEZE Telomerase Detection Kit (Chemicon, Billerica, MA). 186 
2. PBS without Ca2+, Mg2+ (GIBCO). 187 
3. 10--20% nondenaturing polyacrylamide precasted gels. 188 
4. 10✕ TBE (BioRad, Hercules, CA). 189 
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5. SYBR green (Molecular Probes). 190 
6. Loading buffer 10✕ (BioRad). 191 
7. Nondenaturing 10--20% polyacrylamide gel (15% precasted gels from BioRad). 192 
 193 
3. Methods 194 
Extracellular matrix compounds play important roles in cell adhesion, attachment, cell 195 
interactions, and proliferation (18,11). Previous studies have demonstrated that the components 196 
of ECM support undifferentiated growth of hESCs. Extracellular matrix is generally organized 197 
into a three-dimensional fibrous structure and therefore, it is crucial to extract the ECM samples 198 
from human fibroblasts rapidly and at 4º C which prevents conformational changes and protein 199 
degradation. Transmission electron microscopy (TEM) and AFM can be used to assess the 200 
integrity of hffECM after the obtention. To validate functionality, it is very important to evaluate 201 
the ability of the extracted ECM to maintain hESCs in the undifferentiated state. This can be 202 
assessed by long-term growth of hESCs on this ECM and by routine analysis of pluripotency 203 
using the following assays: RT-PCR, immunocytochemistry, determination of alkaline 204 
phosphatase, and telomerase expression and analysis of spontaneous differentiation ability (19). 205 
3.1. Preparation of Fibroblast Cells and Conditioned Media 206 
1. Human foreskin fibroblasts are grown in Iscove’s Medium and the cells are split using Triple 207 
Select every 5--7 days. 208 
2. When confluent, the cells were inactivated using mitomycin C at 37°C in an incubator with 5% 209 
CO2 for 3 h. 210 
3. They are then washed with DPBS three times (5 min), digested, and counted (see Note 2). 211 
4. Seed fibroblast at a density of 6✕106 cells in a T75 flask coated with 0.1% gelatine, and culture 212 
at 37°C with 5% CO2 for 24 h before adding TERS1 medium. 213 
5. TERS1 conditioned medium is collected every day until day 7, and stored at -80°C for up to 6 214 
months (see Notes 3 and 4). 215 
3.2. Preparation of Extracellular Matrix (ECM) 216 
1. Human foreskin fibroblasts are grown in an appropriate medium and the cells are split using 217 
Triple-select every 5--7 days. When the cells reach 100% confluence, they are inactivated by 218 
treatment with mitomycin C (10µg/mL) for 3 h, and then washed three times with DPBS.  219 
2. Cells are detached, counted and seeded (2✕105 cells/per well) in a six-well plates, coated with 220 
0.1% gelatin, and cultured at 37°C and 5% CO2 for 24 h. 221 
3. Inactivated cell cultures are maintained for 7--8 days, with a media change every second day. 222 
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4. Foreskin cultures are treated on day 7, following the recommendations described in (15). 223 
5.Cells are washed twice with DPBS without Ca2+ and Mg2+ and subsequently lysed by osmotic 224 
shock with Tris EDTA buffer (10 mM Tris, 1 mM EDTA, PH 7.4) adding, 1.5 mL per 106 cells. 225 
6. After addition of osmotic shock buffer, cells are incubated o.n. at 4°C using an orbital shaker, 226 
after which time the Tris-EDTA buffer is removed by aspiration (see Note 9). 227 
6. Lysed cells are eliminated from the plates by rinsing six times (5 min each) with DPBS. Plates 228 
containing the remaining hffECM are stored at 4º C or dried and sterilised using standard 229 
methods. Examples of foreskin fibroblast cells and ECM samples studied using TEM are shown 230 
in Fig. 1A. 231 
3.3. Preparation of Samples for TEM (see Notes 6 and 10 when Planning these Experiments) 232 
1. Wash samples twice with PBS for 2--3 min. 233 
2. Fix for 30 min at 37º C with 3% glutaraldehyde. Add glutaraldehyde carefully until the plate 234 
surface is totally covered. 235 
3. Incubate for 30 min and store at 37º C, keeping the samples inside a box or Petri dish to avoid 236 
release of carcinogenic vapor. 237 
4. Aspirate glutaraldehyde with a disposable Pasteur pipette and discard adequately. 238 
5. Wash 3--4 times for 3 min with PBS. 239 
6. Cover the samples with PBS and maintain them at 4º C (see Note 11). 240 
7. Fixation and contrasting: add 1 mL of 2% osmium to cover the plates and leave for 1 h. 241 
8. Wash three times (5 min each) with distilled water at 4º C (do not exceed 15 min). 242 
9. Dehydration procedure (all steps are performed at 4º C): 243 
9.1. Add 30% alcohol for 5 min. 244 
9.2. Wash with 50% alcohol (10 min) at 4º C (exceeding this time can cause protein 245 
damage). 246 
9.3. Wash twice with 70% alcohol (10 min each). 247 
10. Add 1 mL of 2% uranyl acetate in 70% alcohol and incubate for 2 h at 4°C. 248 
11. Continue with the dehydration process by using the following alcohol gradient: 249 
11.1 Add 70% ethanol 2 times ✕ (10 min each). 250 
11.2. Wash with 90% ethanol 2 times ✕ (10 min each). 251 
12. To embed the samples in resin, use the following alcohol/LR white resin (EMS) gradient as 252 
follows: 253 
12.1. Incubate in 2 parts 90% ethanol: 1part resin for 45 min at RT. 254 
12.2. Replace the mixture using a Pasteur pipette and discard adequately. 255 
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12.3. Prepare a dilution 1part 90% ethanol: 2 parts resin, add to the samples and incubate 256 
for 45 min. 257 
12.4. Remove the mixture and discard appropriately. 258 
12.5. Mix 1 part of 100% ethanol and 2 parts resin and incubate for 45 min. 259 
12.6. Replace the mixture by adding 100% LR white resin. Incubate o.n. in an orbital 260 
shaker. 261 
13. To allow polymerization, transfer the samples to an oven and incubate them at 60º C for 24 h. 262 
14. Detach and proceed with the sectioning. 263 
15. Observe the samples under a transmission electron microscope. 264 
3.4. Atomic Force Microscopy (AFM)  265 
AFM provides detailed 3-dimensional images of ECM protein-surface interactions. 266 
1. Samples should be washed in 0.1M PBS and fixed in 2% paraformaldehyde/2.5% 267 
glutaraldehyde/PB for 1 h at room temperature. 268 
3. Samples are dehydrated using a series of ethanol/water solutions (30%, 50%, 70%, 90%, and 269 
96%) for 10 min with final dehydration in absolute ethanol for 10 min twice. 270 
3. The dehydrated samples were examined by AFM, operating in the tapped-air mode. 271 
4. The ECM protein distribution (on glass) is estimated from AFM images. The amplitude set 272 
point should be 1.3 V with a drive amplitude of 300 mV. 273 
5. Surface roughness is calculated by processing 10 representative AFM images. 274 
Images of glass surfaces with and without hffECM captured using AFM are shown in Fig. 1B. 275 
3.5. Growth of Undifferentiated Pluripotent Cells using Feeder-Free Conditions and hffECM 276 
1. Once the ECM-coated plates are ready for use, conditioned medium which has been collected, 277 
should be added. 278 
2. Add 2 mL of conditioned media containing 50 ng/mL and 100 ng/mL of fresh TGF-β1 and 279 
bFGF, respectively. Place the 6-well plates in an incubator at 37º C with 5% CO2 for at least 3 h 280 
before seeding the new hESC colonies. 281 
3. Wash the hESC colonies maintained on human feeders twice with prewarmed DMEM 282 
medium. 283 
4. Dissect hESC colonies mechanically and collect them in a 15 mL polypropylene tube (see 284 
Notes 12and 13). 285 
5. Centrifuge the cells for 3 min at 200 × g and remove the supernatant. 286 
6. Gently resuspend the pellet in conditioned medium supplemented with fresh TGF-ß1 and 287 
bFGF in the same 15 mL tube. 288 
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7. Add 1 mL of media containing 10--20 colonies to each well of the ECM-coated plates. 289 
8. Incubate the plates at 37º C with 5% CO2 and change the media every second day. 290 
9. Undifferentiated hESCs should be transferred to new plates every 5--7 days and maintained at 291 
37º C with 5% CO2. 292 
Examples of contrast phase microscope are shown in Fig. 2A and Fig. 2B. 293 
3.6. Detection of Cell Surface Pluripotency Markers by Immunocytochemistry 294 
1. Remove the culture medium. 295 
2. Wash the cells once with DPBS without Ca2+ and Mg2+. It is important to add the DPBS very 296 
gently and not directly to the cells. 297 
3. Fix hESCs in 4% paraformaldehyde for 15 min at room temperature by adding 1.5 mL/well to 298 
the 6-well plates. 299 
4. Wash 4 times with DPBS. 300 
5. To permeabilize the hESCs, add 1.5 mL per well of 1%Triton-X-100, followed by an 301 
incubation of 10 min at room temperature. 302 
6. Wash twice (5 min each) with DPBS. 303 
7. Apply 4% of blocking solution at room temperature for 45 min. Serum for the blocking 304 
solution should be of the same species as the secondary antibody. 305 
8. Remove the blocking solution but do not wash the cells. 306 
9. Dilute the primary antibody blocking solution (see Table 1).  307 
10. Add 1 mL of the corresponding primary antibody dilution to the cultures for at least 1 h at RT 308 
or overnight at 4º C. 309 
11. Wash 3 times with DPBS. Cells can be left overnight before adding the secondary antibody. 310 
12. Dilute the secondary antibody in DPBS and add 1 mL per well (see Table 2). 311 
13. Incubate at room temperature for 60 min and in darkness as exposure to light may cause 312 
bleaching of fluorescent labels. 313 
14. Wash the cells 4 times with DPBS. 314 
15. If the cells are attached to a coverslip mount it on a slide using prolong gold antifade reagent 315 
with DAPI. Remove any bubbles that may have formed during mounting. 316 
16. Let the slides dry for 15 min in conditions where they are protected from light. 317 
17. After 90 min the samples can be observed using a fluorescence microscope. Examples of the 318 
morphology and undifferentiated hESC surface markers grown on plastic dishes coated by ECM 319 
derived from human fibroblasts and in the presence of conditioned medium are presented in Fig. 320 
2C,D and 3. 321 
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3.7. Preparation of Samples for RT-PCR and QPCR Analysis 322 
Analyzes of mRNA expression by reverse transcription PCR (RT-PCR) and real-time 323 
quantitative PCR (QPCR) are carried out using standard protocols. An RT-PCR reaction is 324 
performed at 60º C and for 35 cycles, except for ß2-microglobulin (performed at 55º C for 35 325 
cycles). The QPCR reaction is performed at 60º C (60 s) and 95º C (15 s) for 40 cycles. Primer 326 
sequences were designed using Primer3 software and synthesized by Sigma-Aldrich. All primer 327 
sequences and DNA fragments are listed in Table 3. Transcripts encoding the following proteins 328 
Oct-4, Tert, Nanog, and FoxD3 should be assessed for pluripotency, and AFP, DBH, and CAC 329 
for differentiation (specific lineage) markers. The ß2-microglobulin gene is used as an 330 
endogenous control (housekeeping) gene. 331 
3.7.1. Extraction and Quantification of Total RNA 332 
Total RNA extraction can be performed using 20 hESC colonies maintained on ECM. As a 333 
positive control, undifferentiated hESCs maintained on feeder cells should be used. We use the 334 
RNeasy mini kit (74104; Qiagen) following provider-recommended instructions with some 335 
modifications. To eliminate contamination by genomic DNA, the initial RNA pellet was 336 
incubated with deoxyribonuclease (DNase) I (RNase-free DNase SET; 79254; Qiagen). 337 
1. Cut the cells from the culture dish with a needle and collect them in a centrifuge tube. 338 
2. Add 350 µL of buffer RLT and vortex for 1 min. 339 
3. Centrifuge the lysate for 3 min at maximum speed. Carefully remove the supernatant by 340 
pipetting out and discarding it. 341 
4. Add 1 volume of 70% ethanol to the homogenized sample and mix well by pipetting only (do 342 
not centrifuge). The volume might be less than 350 µL due to loss during the homogenization 343 
process. The use of ethanol can trigger precipitates to form; however, their presence has no 344 
impact on the process. 345 
5. Transfer up to 700 µL from the sample, including any precipitates, to an RNeasay mini spin 346 
column (pink) placed in a 2 mL collection tube, and close the lid. 347 
6. Centrifuge at 8,000 × g (10,000 rpm) for 15 s, discard the flow-through and reuse the 348 
collection tube for step 7. Note: if the sample volume is greater than 700 µL, the aliquots must be 349 
centrifuged one after the other in the same column, discarding the flow-through after each 350 
centrifugation. 351 
7. Add 350 µL RW1 buffer to the RNeasy mini spin column, close the lid, and centrifuge at 8,000 352 
x g (10,000 rpm) for 15 s. Discard the flow-through and reuse the collection tube for step 10. 353 
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8. Add 10 µL DNase I stock solution to 70 µL RDD buffer. Mix by gently inverting the tube; 354 
centrifuge briefly to collect the liquid from the tube walls. 355 
9. Add DNase I to the incubation mix (80 µL) and transfer it directly to the RNeasy column 356 
membrane, and it place on the benchtop at 20--30°C for 15 min. 357 
10. Add 350 µL RW1 buffer to the RNeasy mini spin column, close the lid, and centrifuge at ≥ 358 
8,000 x g for 15 s. Discard the flow-through. 359 
11. Add 500 µL RPE buffer to the RNeasy mini spin column, close the lid, and centrifuge at ≥ 360 
8,000 x g for 15 s. Discard the flow-through and reuse the collection tube. 361 
12. Add 500 µL RPE buffer to the RNeasy mini spin column, close the lid, and centrifuge at ≥ 362 
8,000 x g for 2 min to wash the column membrane. 363 
13. Place the RNeasy mini spin column in a new 2 mL collection tube and centrifuge at full speed 364 
for 1 min to dry the membrane (optional step). 365 
14. Place the RNeasy mini spin column in a new 1.5 mL collection tube and add 30--50 µL 366 
RNase-free water directly to the spin column membrane. Close the lid, and centrifuge at ≥ 8,000 367 
x g for 1 min to elute the RNA. 368 
15. If the expected RNA yield is >30 µg, repeat step 14 using another 30--50 µL RNase-free 369 
water, or the elute from step 14 (if a high RNA concentration is required). Reuse the collection 370 
tube from step 14. Note: if the elute from step 14 is used, the RNA yield might be 15--% lower 371 
than using a second volume of RNase-free water but the final RNA concentration will be higher 372 
(see Note 14). 373 
16. Quantify the extracted RNA and evaluate its quality using a NanoDrop spectrophotometer or 374 
a RNA-integrity gel. Either use the eluted RNA directly in following steps (RT-PCR and QPCR) 375 
or store the eluted RNA at -80º C for later analysis. 376 
 377 
3.7.2. cDNA Synthesis 378 
Use 50 µL from each sample obtained for total RNA to single-stranded cDNA reverse 379 
transcription (RT). We follow the recommendations from the High Capacity cDNA RT kit (PN 380 
4368814, Applied Biosystems). 381 
1. Place the 2✕ RT master mix on ice and mix gently. 382 
2. Pipette 25 µL of 2✕ RT master mix into each well of an individual tube (see Note 15). 383 
3. Pipette 25 µL of RNA sample into each well, pipetting up and down two times to mix (see 384 
Note 16). 385 
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4. Seal the tubes and briefly centrifuge them to spin down the contents and to eliminate any air 386 
bubbles. 387 
5. Place the plate or tubes on ice until you are ready to load them into the thermal cycler. 388 
6. Program the thermal cycler conditions with the following parameter steps: (i) step 1: 25 º C for 389 
10 min; (ii) step 2: 37 º C for 120 min; (iii) step 3: 85 º C for 5 min; (iv) step 4: 4 º C for 390 
indefinite time. 391 
7. Set the reaction volume to 20 µL. 392 
8. Load the reactions into the thermal cycler and start the reverse transcription run. 393 
9. Quantify the synthetized cDNA and evaluate its quality using a NanoDrop spectrophotometer 394 
or cDNA integrity gel. 395 
3.7.3. PCR Analysis 396 
Use a 50 µL reaction per sample to obtain the PCR products. We follow the recommendations 397 
from FastStart PCR Master (04710436001; Roche). 398 
1. Prepare the microplates for PCR according to the instrument instructions. 399 
2. Thaw the solutions and briefly spin the vials in a microcentrifuge before opening. 400 
3. Mix the solutions by pipetting them up and down gently and store them on ice. 401 
4. Prepare 10✕ concentration solutions of the PCR primers (see Table 3) 402 
5. Prepare a PCR mix for the number of reactions to be run plus one additional reaction. The PCR 403 
mix contains the following products for each reaction in the following order: 25 µL 2✕ master 404 
mix, 5 µL forward primer (3 µM), 5 µL reverse primer (3 µM), and 10 µL PCR-grade water. 405 
6. Mix the solution by pipetting it up and down (do not vortex). 406 
7. Transfer 45 µL PCR mix into each reaction well of the PCR microplate. 407 
8. Add 5 µL of template DNA (up to 100 ng cDNA) into each reaction well. 408 
9. Prepare the microplate for the PCR reaction according to the instrument’s instructions. 409 
10. Program the thermal cycler conditions with following steps: (i) step 1: 1 cycle at 95º C for 4 410 
min; (ii) step 2: 30 to 40 cycles at 95º C for 30 s, and 45--65º C for 30 s, and 72º C for 45--180 s; 411 
(iii) step 3: 1 cycle at 72 º C for 7 min; (iv) step 4: 4º C for an indefinite time. 412 
7. Set the reaction volume to 50 µL. 413 
8. Load the microplate into the thermal cycler and start the PCR reaction. 414 
The results can be observed in the electrophoresis gels on Fig. 4B and Fig. 4C. 415 
3.7.4. QPCR Analysis 416 
1. Completely thaw the Power SYBR Green PCR Master Mix and gently mix the reagents. 417 
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2. In polypropylene tubes, prepare the PCR reagent mix for the desired number of PCR 418 
reactions. Each 20 µL PCR reaction contains 10 µL of the PCR Master Mix, 50--300 nM from 419 
each primer, 100 ng template, and a variable quantity of nuclease-free water (see Note 17). 420 
3. Mix gently (do not vortex) and centrifuge briefly. 421 
4. Prepare the microplate for the QPCR reactions according to instrument’s instructions. 422 
5. Program the thermal cycler conditions with the following steps: (i) step 1: 1 cycle at 95º C for 423 
4 min; (ii) step 2: 30 to 40 cycles at 95º C for 30 s, 45--65º C for 30 s, and 72º C for 45--180 s; 424 
(iii) step 3: 1 cycle at 72 º C for 7 min; (iv) step 4 at 4 º C for an indefinite time. 425 
6. Set the rest of the thermal cycler parameters (e.g., volume = 20 µL) following instrument 426 
user’s manual to configure the plate documentation details. 427 
7. Load the microplate into the thermal cycler and start the PCR reaction. 428 
8. Analyze and export the results using a spreadsheet program with statistical features. 429 
9. Calculate the average cycle time, the standard deviation, and the coefficient of variation for 430 
each group of replicates of any sample. Remove outlier points (Ct > 0.3 ✕ standard deviation). 431 
10. Apply the ∆∆Ct method to obtain “fold changes” as desired output (20). The internal control 432 
selected is ß-2 microglobulin gene. 433 
3.8. Telomerase activity assay 434 
Telomerase activity is assayed using telomeric repeat amplification protocol using the Trapeze 435 
Kit (Chemicon) and according to the manufacturer’s protocol but with some modifications. 436 
3.8.1 Sample Preparation 437 
1. For stem cell analysis, collect 30--100 colonies. Pellet cells at 400 × g for 5 min at 4º C. We 438 
highly recommend that the positive and negative controls provided with the kit and a negative 439 
control (a differentiated cell line and/or heat inactivated immortal/stem cells) be used. 440 
2. Wash cell pellet with sterile Ca2+ and Mg2+ free PBS for 5 min at 400 × g at 4º C. 441 
3. Resuspended the cell pellet with 5--20 µL CHAPS lysis buffer (Thermo Scientific) for stem 442 
cell colonies. 443 
4. Place on ice for 30 min. 444 
5. Pellet cells at high speed (12,000 rpm) at 4º C for 20 min. 445 
6. Transfer the supernatant to a new tube. At this point the supernatants are kept at -80º C and can 446 
be stored for up to one year to be used for telomerase detection. 447 
 448 
3.8.2 PCR reaction 449 
1. Use 2--4 µL of sample per PCR reaction. 450 
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2. Heat inactivated negative controls must be subjected to 85º C for ten min. Then use the same 451 
2--4 µL volume for the PCR reactions. 452 
3. Prepare a master mix containing all these components except the templates, all the reagents are 453 
provided by the kit except Taq polymerase: 454 
• 10✕ TRAP Reaction buffer 5 µL 455 
• 50✕ dNTP mix   1 µL 456 
• TS primer    1 µL 457 
• TRAP primer mix  1 µL 458 
• Taq polymerase (5 U/µL) 0.4 µL 459 
• dH2O    29.5 µL 460 
• Template    2 µL 461 
4. PCR program 462 
• 1 cycle:    30º C 30 min 463 
• 30--33 cycles:   94º C 30 s 464 
59º C 30 s 465 
3.8.1 Separation by Electrophoresis 466 
1. For sample electrophoresis, use a 10--15 µl PCR reaction with a 2--5 µl loading buffer 10✕ 467 
(BioRad). 468 
2. Load a nondenaturing 10--20% polyacrylamide gel (we use 15% precasted gels from BioRad). 469 
3. Run the gel in TBE 0.5X until both color bands are out of the gel. 470 
4. Prepare the SYBR green solution (1/10,000) in TBE 1X. 471 
5. Stain the gel for 15--20 min in the dark. 472 
6. Visualize the bands in a transilluminator (with the same wavelength as the ethidium bromide). 473 
The results for telomerase activity are presented in Fig. 4D. 474 
 475 
4. Notes 476 
1. Conditioned media can be prepared using foreskin fibroblasts between passages 11--18, but in 477 
order to maintain the quality, we recommend that cells between passages 11 to 16 be used. 478 
2. Cell counting: take 20 µL of cell suspension and dilute it with 70 µL of culture medium. Add 479 
10 µL of Trypan Blue solution (Sigma), mix, and incubate for 1 min before counting viable 480 
(round, clear cells) and nonviable (blue) cells using a Neubauer haemocytometer and plate 6✕106 481 
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cells per flask or 2✕105 cells per well for 75 cm2 flasks and 6-well plates respectively. More 482 
than 75% of cells should be viable.  483 
3. Before using of conditioned TESR1 medium, add 100 ng/mL of bFGF and 50 ng/mL of TGF-484 
β1. Conditioned medium can be kept at +4°C for 1 week or stored at -80º C for 6 months. 485 
4. No differences between frozen and fresh conditioned media have been observed. 486 
5. Lysis buffer preparation. The following is an example for 250 mL: 487 
• 2.5 mL 1 M Tris-HCl pH 7.4 488 
• 500 µL 0.5 M EDTA pH 8.0 489 
• 247 mL H2O 490 
Stock Solutions: 491 
o 1 M Tris-Cl, pH 7.4 (1 L): 492 
§ 121 g Tris Base 493 
§ 1 L H2O 494 
Adjust pH 495 
o 0.5 M EDTA (1 L): 496 
§ 186.1 g EDTA Na2H2O 497 
§ 1 L H2O 498 
Adjust pH 499 
 500 
6. TEM inclusion procedure: Glutaraldehyde is carcinogenic by inhalation, it is important to 501 
manipulate it in a fume hood. During the 37º C incubation it is very important to avoid inhaling 502 
these fumes, keeping the culture plates inside a petri dish in the special stove. Osmium is 503 
carcinogenic and toxic by inhalation and contact and so double gloves and a mask should be 504 
worn, in addition to working under fume hood. Uranyl acetate is carcinogenic and radioactive. 505 
Manipulation must be performed in an adequate installation under fume hood using double 506 
gloves and a mask. Given their toxicity, those residues need to be manipulated and discarded 507 
properly.  508 
7. Try to avoid bubbles in the samples. 509 
8. Do not use until the solution reaches room temperature and adjust the pH if necessary. 510 
9. We have also performed this process by incubating with ice in the orbital shaker for 2.5 hours. 511 
10. When planning to do TEM analysis, the seeding of hFFs, the cell lysis and subsequent 512 
pluripotent cell seeding needs to be done on Permanox® chambers.  513 
11. At this point, the plates can be maintained for several days at 4°C by adding sodium azide. 514 
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12. hESCs were cultured and maintained as previously described (21). Cells were passaged 515 
mechanically and re-plated on ECM-coated plates. 516 
13. The optimal size of hESCs before the splitting procedure is when the colonies completely 517 
cover the magnification field (x10). 518 
14. If you use the elution obtained in step 10, the quantity of RNA obtained may be 15--30% less 519 
than using RNase-free water.  520 
15. The kit reagents must always be thawed on ice. 521 
16. Use up to 5 µg of total RNA per 50 µL RT reaction. 522 
17. Include an extra volume to account for pipetting losses. 523 
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Figure Captions 533 
 534 
Fig. 1. Transmission electron microscopy (TEM) and atomic force microscopy (AFM) of the 535 
hffECM after the extraction to evaluate structural integrity and roughness. (A) Ultrastructural 536 
analysis of the efficiency of the extraction protocol using TEM. Plates of lysed cultures and their 537 
respective controls with intact foreskin fibroblasts were fixed and processed for TEM 538 
ultrastructural analysis. Human foreskin fibroblasts (hFFs) were maintained for the indicated 539 
times and then subjected to hypotonic lysis. (A.1 and A.3) Semi-thin sections were prepared from 540 
control and lysed cultures and were stained with toluidine blue. (A.2) Representative TEM image 541 
of intact hFF control cells after 7 days in culture. (A.4) Representative TEM image of lysed 542 
culture plate after 7 days in culture. Scale bars, 200 µm (A.1 and A.3), 1 µm (A.2), 500nm (A.4). 543 
(B) AFM analysis of ECM conformation on glass surfaces. The images show the amplitude mode 544 
with the same scale. (B.1) The smallest roughness corresponds to fibronectin that was used as 545 
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experimental control. The mean surface roughness observed demonstrates that the surface 546 
roughness is significantly lower on day 1 (B.2) than after hFFs culture on day 2 (B.3). Scale bars 547 
250 nm (Figures 1.A.1 and 1.A.3 reproduced from (12) with permission from Springer). 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
Fig. 2. (A and B) Morphology of undifferentiated hESCs grown for 11 passages over feeder cells 557 
and on plastic coated with hffECM using conditioned media respectively. (C and D) Images 558 
showing alkaline phosphatase activity in both feeder and hffECM conditions, indicating 559 
maintenance of pluripotency. Images were obtained using Zeiss Axiovert 200M microscope 560 
(magnifications ×100). 561 
 562 
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 563 
Fig. 3. Morphology and cell surface markers of undifferentiated hESC grown for 11 passages on 564 
plastic dishes coated with hffECM derived from human fibroblasts and in the presence of 565 
conditioned medium. Note round and compacted hESC colonies. The presence of SSEA4 (A--C, 566 
magenta), Tra1-81 (D--F, green), Tra1-60 (H--J, green), pluripotency markers were observed. 567 
Note the presence of specific fibronectin staining (G--J and R-U). 568 
Morphology and cell surface markers of undifferentiated hESCs grown for 11 passages over hFFs 569 
feeder. The presence of SSEA4 (K--M, magenta), TRA-1-81 (O--K, green), TRA-1-60 (S--U, 570 
green), pluripotency markers were observed. Note the presence of specific fibronectin staining (G 571 
and J). Images were obtained using confocal microscope (10✕ magnifications). 572 
Growth of hPSCs using functional hECM 
DOI 10.1007/7651_2014_154 Springer Science & Business Media New York 
21 
 573 
 574 
Fig. 4. Analysis of specific molecular hESC markers and telomerase activity. hESCs were grown 575 
on hffECM and in the presence of conditioned medium for 11 passages. Controls over foreskin 576 
feeder were also and grown at the same time. (A) QPCR comparing expression of pluripotency 577 
and differentiation genes in cells maintained on hffECM and hFF. The expression of 578 
characteristic pluripotent markers is higher in the cells maintained on hffECM than on hFF. This 579 
indicates that our system is highly selective and only cells with the best quality are able to adapt 580 
and survive. No expression of differentiation markers (AFP, DBH and CAC) was detected. (B 581 
and C) Cells maintained on hffECM and foreskin feeders respectively. Line 1 and 10: Ladders 582 
with 1Kb; 2. Corresponds to negative control; 3. Housekeeping gene ß-2 microglobulin. Cells 583 
express all the typical hESC markers 4. Nanog; 5. Oct-4; 6. Tert; 7. FoxD3. After 11 passages on 584 
ECM the cells were negative for differentiation markers AFP and CAC (lines 8 and 9, 585 
respectively. (D) Colonies retained telomerase activity after 11 passages on hffECM (line 3). 586 
Line 4 corresponds to their H9 counterparts maintained 11 passages over foreskin feeder cells. 587 
Line 1 and 6 are negative controls, and the line 2 the positive control. 588 
589 
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Table  590 
 591 
Table 1. List of primary antibodies 592 
 593 
 594 
Primary antibody Isotype Working dilution Catalogue number Provider 
SSEA4 IgG3 1:100 MAB 4304 Chemicon 
Tra1-81 IgM 1:100 MAB 4381 Chemicon 
Tra1-60 IgM 1:100 MAB 4360 Chemicon 
Fibronectin IgG1 1:100 F0916 Sigma 
*SSEA4, Tra1-81, Tra1-60, and AP can also be acquired as a kit (SCR001; Chemicon). 595 
 596 
 597 
 598 
 599 
 600 
 601 
 602 
603 
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 604 
Table 2. List of secondary antibodies 605 
 606 
Secondary antibody Working dilution Catalogue number Provider 
Alexa Fluor goat against IgG 1:500 A11029 Invitrogen 
Alexa Fluor against IgM 1:500 A21042 Invitrogen 
Alexa Fluor against IgG1 1:500 A21124 Invitrogen 
 607 
 608 
 609 
 610 
611 
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 612 
Table 3. List of primers and conditions used for both RT-PCR and qPCR 613 
 614 
 615 
Gene Name Primer Sequences Annealing Temperature (º C) Size (bp) Detection 
Housekeeping gene 
ß2-microglobulin 
F: CTCGCGCTACTCTCTCTTTCTG 
R: GCTTACATGTCTCGATCCCACT 55 335 
RT-PCR 
QPCR 
Pluripotency assay genes 
Nanog 
F: GGTGGCAGAAAAACAACTGG 
R: CATCCCTGGTGGTAGGAAGA 60 235 RT-PCR 
Nanog 
  F: AATGGTGTGACGCAGAAGG 
R: ACTGGATGTTCTGGGTCTGG 
60 157 QPCR 
Oct-4 
F: cctgtctccgtcaccactct 
R: CAAAAACCCTGGCACAAACT 60 128 
RT-PCR 
QPCR 
FoxD3 
  F: CAGAGCCCGCAGAAGAAG 
R: CGAAGCAGTCGTTGAGTGAG 60 133 RT-PCR 
FoxD3 
F: GCCCAAGAACAGCCTAGTGA 
R: GGGTCCAGGGTCCAGTAGTT 60 254 QPCR 
Tert 
F: GACCTCCATCAGAGCCAGTC 
R: CGCAAGACCCCAAAGAGTT 60 84 RT-PCR 
Tert 
F: GCGTTTGGTGGATGATTTCT 
R: AGCTGGAGTAGTCGCTCTGC 
60 254 QPCR 
Differentiation assay genes 
AFP 
F: TGCGTTTCTCGTTGCTTACA 
R: GCTGCCATTTTTCTGGTGAT 
60 81 RT-PCR 
AFP 
F: Acacaaaaagcccactccag 
R: ggtgcatacaggaagggatg 60 
147 QPCR 
DBH 
F: tgactgggagaaaggtggtc 
R: tacgtgcaggaggtgatgag 60 160 QPCR 
CAC 
F: tgctgatcgtatgcagaagg 
R: gctggaaggtggacagagag 60 135 
RT-PCR 
QPCR 
 616 
 617 
 618 
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